Target
Cytochrome P450 2C9
Ligand
BDBM50567991
Substrate
n/a
Meas. Tech.
ChEMBL_2104170 (CHEMBL4812673)
IC50
12000±n/a nM
Citation
 Palmer, MJDeng, XWatts, SKrilov, GGerasyuto, AKokkonda, SEl Mazouni, FWhite, JWhite, KLStriepen, JBath, JSchindler, KAYeo, TShackleford, DMMok, SDeni, ILawong, AHuang, AChen, GWang, WJayaseelan, JKatneni, KPatil, RSaunders, JShahi, SPChittimalla, RAngulo-Barturen, IJiménez-Díaz, MBWittlin, STumwebaze, PKRosenthal, PJCooper, RAAguiar, ACCGuido, RVCPereira, DBMittal, NWinzeler, EATomchick, DRLaleu, BBurrows, JNRathod, PKFidock, DACharman, SAPhillips, MA Potent Antimalarials with Development Potential Identified by Structure-Guided Computational Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series. J Med Chem 64:6085-6136 (2021) [PubMed]  Article 
Target
Name:
Cytochrome P450 2C9
Synonyms:
(R)-limonene 6-monooxygenase | (S)-limonene 6-monooxygenase | CP2C9_HUMAN | CYP2C10 | CYP2C9 | CYPIIC9 | Cytochrome P450 2C9 (CYP2C9 ) | Cytochrome P450 2C9 (CYP2C9) | P-450MP | P450 MP-4/MP-8 | P450 PB-1 | S-mephenytoin 4-hydroxylase
Type:
Enzyme
Mol. Mass.:
55636.33
Organism:
Homo sapiens (Human)
Description:
P11712
Residue:
490
Sequence:
MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFMKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYIDLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFKKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVPPFYQLCFIPV
  
Inhibitor
Name:
BDBM50567991
Synonyms:
CHEMBL4848632 | US11903936, Compound 2
Type:
Small organic molecule
Emp. Form.:
C19H19F3N6O
Mol. Mass.:
404.389
SMILES:
CC(NC(=O)c1[nH]cc(c1C)C1(CC1)c1ccc(nc1)C(F)(F)F)c1nc[nH]n1
Structure:
Search PDB for entries with ligand similarity: